TITLE

THE CONTRAST RESEARCH IN SAFETY AND EFFICACY BETWEEN NADROPARIN AND DALTEPARIN BEFORE ELECTIVE PERCUTANEOUS CORONARY INTERVENTION

PUB. DATE
October 2010
SOURCE
Heart;Oct2010 Supplement, pA128
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "The Contrast Research in Safety and Efficacy Between Nadroparin and Dalteparin Before Elective Percutaneous Coronary Intervention" by Liu Ruifang and Yan Hongbing is presented.
ACCESSION #
66245815

 

Related Articles

  • A comparative study of dalteparin and unfractionated heparin in patients with unstable angina pectoris. Amane, Hanmant S.; Burte, N. P. // Indian Journal of Pharmacology;Dec2011, Vol. 43 Issue 6, p703 

    Objective: To compare the efficacy and safety profile of dalteparin, a low-molecular-weight heparin with a standard unfractionated heparin in patients with unstable angina pectoris. Materials and Methods: This was a 6-month, prospective, parallel, randomized and open-labeled study. Patients of...

  • Dalteparin sodium.  // Reactions Weekly;10/1/2011, Issue 1371, p14 

    The article describes the case of an 80-year-old woman who developed heparin-induced thrombocytopenia following treatment with dalteparin sodium.

  • Dalteparin sodium overdose.  // Reactions Weekly;1/15/2011, Issue 1334, p18 

    The article describes the case of a 39-year-old woman who developed increased activated partial thromboplastin time (APTT) and prothrombin time (PT) after an overdose of dalteparin sodium in a suicide attempt.

  • Dalteparin sodium/enoxaparin sodium overdose.  // Reactions Weekly;12/18/2010, Issue 1332, p17 

    The article describes the case of two patients who developed increased anti-Xa activity and international normalised ratio (INR) after intentional overdoses of low molecular weight heparins such as dalteparin sodium and enoxaparin sodium.

  • Dalteparin sodium/enoxaparin sodium/nadroparin calcium.  // Reactions Weekly;1/14/2012, Issue 1384, p22 

    The article describes the case of a 63-year-old man who developed a life-threatening haemorrhage after he started receiving dalteparin sodium, enoxaparin sodium and nadroparin calcium following aortic valve replacement.

  • Dalteparin sodium.  // Reactions Weekly;12/15/2012, Issue 1432, p20 

    The article describes the case of a 52-year-old man, diagnosed with alpha-1 antitrypsin deficiency (AATD), who developed toxic and cholestatic hepatitis while under dalteparin sodium treatment regimen.

  • Dalteparin sodium.  // Reactions Weekly;8/4/2012, Issue 1413, p19 

    The article describes the case of an 82-year-old woman who developed heparin-induced thrombocytopenia, complicated with deep vein thrombosis (DVT), during haemodialysis with dalteparin sodium for renal failure.

  • Dalteparin and Heparin-Induced Thrombocytopenia.  // New England Journal of Medicine;9/22/2011, Vol. 365 Issue 12, p1158 

    A letter to the editor is presented in response to an article which compared unfractionated heparin with dalteparin for the prevention of venous thromboembolism in critically ill patients in the April 7, 2011 issue.

  • THE SAFETY AND EFFICIENCY OF DALTEPARIN DURING PERCUTANEOUS CORONARY INTERVENTION.  // Heart;Oct2010 Supplement, pA168 

    An abstract of the article "The Safety and Efficiency of Dalteparin During Percutaneous Coronary Intervention" by Shi Xu-bo, and colleagues is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics